, /PRNewswire/ -- At the Structural Heart Summit earlier today, Dr. ( & White, The Heart Hospital Plano TX) delivered the scientific presentation: Dr. Covas highlighted the unmet need for an AI system for aortic stenosis – a form of heart valve disease characterised by high rates of mortality when untreated.
He revealed that the condition is underdiagnosed and undertreated worldwide, partly due to the complexity in the diagnosis of severe aortic stenosis (including low-flow states), and that there is a need for assistance to improve rates of diagnosis. As backed up by the research presented by Dr. Covas, Echo IQ uses artificial intelligence to aide in identifying a high-risk phenotype of aortic stenosis, to ultimately help with timely diagnosis and treatment.
The independent research presented by Dr. Covas considered whether artificial intelligence could improve accuracy and reproducibility of diagnosis of severe aortic stenosis in a real-world hospital setting. To test this, The findings showed EchoSolv to be successful in identifying more patients at risk of aortic stenosis than human-only diagnosis.
Specifically, The research concluded that: Echo IQ Chief Medical Advisor, Professor said: "This kind of independent research demonstrates exactly how Echo IQ's artificial intelligence can help healthcare professionals identify patients with severe cases of aortic stenosis as well as those with significant risk of disease. Diagnosing aortic stenosis accurately, and in a timely.
